Bhagiradha Chem Peer Comparison

NSE: BHAGCHEM | BSE: 531719

₹205.93

₹4.95 (2.46%)

As on 28-Oct-2026IST

Market cap

₹2,654 Cr

Revenue (TTM)

₹607 Cr

P/E Ratio

96.4

P/B Ratio

3.7

Div. Yield

0.1 %

Edit

	Bhagiradha Chem	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Rallis India
Market cap (₹ Cr)	2,654	16,749	14,744	6,160	3,678
Revenue (₹ Cr)	607	3,222	5,595	5,357	2,959
Net Profit (₹ Cr)	27.53	559.03	732.10	626.21	197.00
Net Margin (%)	4.51	16.53	12.71	11.46	6.57
RoE (%)	3.97	15.55	24.05	21.55	11.92
Price to Earnings	96.42	29.97	20.14	9.84	18.67
Price-To-Book	3.73	4.53	4.49	1.91	1.68

Income Statement (₹ Cr)

	Bhagiradha Chem	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Rallis India
Operating Revenue	607.18	3,222.38	5,595.40	5,356.54	2,959.00
Total Income	610.69	3,382.38	5,760.60	5,464.12	3,000.00
Total Expenditure	528.51	2,569.67	4,702.50	4,309.62	2,591.00
EBITDA	78.68	652.70	892.90	1,046.92	368.00
Depreciation	25.41	68.14	116.90	346.70	120.00
EBIT	53.28	584.56	776.00	700.22	248.00
Interest	20.63	7.85	19.40	3.01	7.00
Other Income	3.51	160.00	165.20	107.59	41.00
Exceptional Items	0.00	10.82	0.00	0.00	-16.00
Profit before Tax	36.15	747.53	921.80	804.80	266.00
Provision for Tax	8.63	188.50	189.70	178.58	69.00
Profit after Tax	27.53	559.03	732.10	626.21	197.00

	Bhagiradha Chem	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Rallis India
Shareholder's Funds	698.32	3,696.73	2,965.70	3,136.49	2,192.00
Minority Interest	0.00	-0.11	0.00	-0.09	0.00
Non-Current Liabilities	176.33	89.56	166.20	257.07	113.00
Current Liabilities	245.54	1,189.21	2,567.50	2,386.20	1,125.00
Total Liabilities	1,120.19	4,473.76	9,033.00	5,890.22	4,248.66

	Bhagiradha Chem	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Rallis India
Non-Current Assets	671.02	1,414.39	598.20	1,259.56	822.00
Current Assets	436.49	3,462.62	4,918.30	4,438.10	2,369.00
Total Assets	1,120.19	4,473.76	9,033.00	5,890.22	4,248.66
Total Debt*	230.90	1.50	0.00	0.00	6.90
Net Current Assets	190.94	2,273.41	2,350.80	2,051.90	1,244.00
Contingent Liabilities	154.21	60.07	765.30	17.55	274.02

	Bhagiradha Chem	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Rallis India
Cash From Operating Activities	12.01	445.51	1,078.50	655.69	172.11
Cash Flow from Investing Activities	-160.17	-331.95	72.50	-513.07	-94.88
Cash from Financing Activities	136.28	-82.88	-623.80	-118.28	-66.16
Net Cash Inflow / Outflow	-11.88	30.68	527.20	24.34	11.07

	Bhagiradha Chem	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Rallis India
ROCE (%)	4.55	23.39	30.08	31.10	13.23
ROE (%)	3.97	15.55	24.05	21.55	11.92
ROA (%)	2.68	11.87	13.38	11.92	5.83
EBIT Margin (%)	8.77	18.14	13.87	13.07	8.38
Net Margin (%)	4.51	16.53	12.71	11.46	6.57
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Bhagiradha Chem	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Rallis India
Revenue Growth (%)	34.08	-2.59	-2.80	18.52	6.82
EBIT Growth (%)	173.75	-1.75	22.55	68.35	18.10
Net Profit Growth (%)	126.92	2.94	23.56	49.11	11.93
EPS Growth (%)	120.02	1.51	23.56	49.11	47.85
Book Value Growth (%)	2.36	16.84	4.05	25.43	7.28

	Bhagiradha Chem	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Rallis India
Price / Earnings	96.41	30.41	20.14	9.84	14.57
Price / Book Value	3.73	4.53	4.49	1.91	1.68
Dividend Yield (%)	0.07	0.39	4.57	2.20	1.59
EV/EBITDA	36.42	24.12	14.86	5.33	8.53
Market Cap (₹ Cr)	2,221.22	18,203.86	20,885.70	7,846.59	4,235.19

	Bhagiradha Chem	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Rallis India
Debt to Equity	0.22	0.00	0.00	0.00	0.00
Short term debt to equity ratio	0.10	--	--	--	0.00
Current Ratio	1.78	2.91	1.92	1.86	2.11
Quick Ratio	1.18	2.28	1.08	1.39	1.19
Interest Coverage	2.75	96.20	48.52	268.73	39.00

	Bhagiradha Chem	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Rallis India
Debtors to sales (%)	33.71	27.52	19.94	44.60	32.00
Asset Turnover	0.59	0.68	1.02	1.02	0.88
Receivable days	128.90	77.14	56.33	142.20	57.86
Inventory Days	93.80	74.64	122.54	68.45	85.52
Payable days	127.50	95.86	131.57	151.79	126.20
Cash Conversion Cycle	95.21	55.92	47.30	58.86	17.18

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.